A. Blancafort

Cell-penetrating γ-peptide/antimicrobial undecapeptide conjugates with anticancer activity

F. Albericio, E. Bardaji, L. Feliu, 2012 .

Different fatty acid metabolism effects of (−)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung cancer

D. Haro, S. Cufí, P. Marrero, 2012, BMC Cancer.

Fatty acid synthase expression is strongly related to menopause in early-stage breast cancer patients

R. Porta, A. Blancafort, G. Oliveras, 2014, Menopause.

New synthetic inhibitors of fatty acid synthase with anticancer activity.

M. Artola, D. Haro, M. López-Rodríguez, 2012, Journal of medicinal chemistry.

Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs

R. Brugada, M. Palafox, A. Massaguer, 2015, PloS one.

Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer

A. Welm, Ariadna Sarrats, D. Lum, 2016, Clinical Cancer Research.

Novel anti‐fatty acid synthase compounds with anti‐cancer activity in HER2+ breast cancer

R. Brugada, A. Urruticoechea, M. López-Rodríguez, 2010, Annals of the New York Academy of Sciences.